Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.82 USD
-0.03 (-1.62%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.81 -0.01 (-0.55%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Tilray Brands, Inc. [TLRY]
Reports for Purchase
Showing records 141 - 160 ( 219 total )
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Canadian LPs: Mixed Outlook with Regulatory, Limited Retail, and 2.0 Overhangs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Canada Industry Overhangs Continue, Lowering Estimates and Outlook
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Receives GMP Certification at EU Campus, Allows for International Export
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
3Q19 Strong Revenue Results, Nearing an Inflection
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S